Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Glutaminyl Cyclase Inhibitor 6 (compound BI-43) functions as an inhibitor of both secretory glutaminyl cyclase (sQC) and golgi-resident glutaminyl cyclase (gQC), with IC50 values of 0.012 µM and 0.040 µM, respectively. This compound also holds potential for research in Parkinson's disease.

| Description | Glutaminyl Cyclase Inhibitor 6 (compound BI-43) functions as an inhibitor of both secretory glutaminyl cyclase (sQC) and golgi-resident glutaminyl cyclase (gQC), with IC50 values of 0.012 µM and 0.040 µM, respectively. This compound also holds potential for research in Parkinson's disease.  | 
| In vivo | Compound BI-43, a Glutaminyl Cyclase Inhibitor, administered intraperitoneally at doses of 10, 25, or 40 mg/kg daily for 7 days, has demonstrated efficacy in alleviating motor dysfunction induced by MPTP in various behavioral performance tests.  | 
| Formula | C27H23N5O3 | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.